Literature DB >> 24418685

Characterization of patients aged 45 or under admitted with hypertensive emergencies in the Hospital do Prenda.

Geovedy Martínez García1, Venâncio Miúdo2, Conceição da Graça Alves Manuel Lopes2, Juliana Vassuelela Gomes2.   

Abstract

INTRODUCTION AND
OBJECTIVES: The incidence and prevalence of hypertensive emergency have been little addressed in the literature. However, over the last decade increasing numbers of young patients with different forms of hypertensive crisis have been observed in emergency departments. We performed this study to ascertain the clinical and epidemiological characteristics of patients aged ≤ 45 years admitted with a diagnosis of hypertensive emergency.
METHODS: We conducted an observational, descriptive, cross-sectional prospective study of 123 patients hospitalized for hypertensive emergency in the Hospital do Prenda, Luanda, between May 2011 and June 2012.
RESULTS: Mean age was 36.62 ± 5.49 years, and most were male (52.85%). The main risk factor was hypertension (65.9%), with 17.3% complying with therapy. The most frequent forms of presentation were hypertensive encephalopathy and hemorrhagic stroke (9.8% and 82.1%, respectively). The main drugs used were diuretics, angiotensin-converting enzyme inhibitors and calcium channel blockers. Mortality during hospitalization was 25.2% (31 patients), hemorrhagic stroke being the most common cause. There was a significant association between age and in-hospital mortality.
CONCLUSIONS: Of patients admitted with hypertensive emergency, 30.1% were aged ≤ 45 years. Hemorrhagic stroke was the most common presentation. There was a significant relationship between mode of presentation, age and in-hospital mortality.
Copyright © 2013 Sociedade Portuguesa de Cardiologia. Published by Elsevier España. All rights reserved.

Entities:  

Keywords:  Emergência hipertensiva; Hypertensive emergency; Incidence; Incidência; Mortalidade; Mortality

Mesh:

Year:  2014        PMID: 24418685     DOI: 10.1016/j.repc.2013.04.017

Source DB:  PubMed          Journal:  Rev Port Cardiol        ISSN: 0870-2551            Impact factor:   1.374


  6 in total

1.  Prevalence of Hypertensive Emergency and Associated Factors Among Hospitalized Patients with Hypertensive Crisis: A Retrospective Cross-Sectional Study.

Authors:  Desilu Mahari Desta; Dawit Zewdu Wondafrash; Afewerki Gebremeskel Tsadik; Gebremicheal Gebreslassie Kasahun; Segen Tassew; Teklu Gebrehiwot; Solomon Weldegebreal Asgedom
Journal:  Integr Blood Press Control       Date:  2020-08-18

2.  Incidence, aetiology and mortality secondary to hypertensive emergencies in a large-scale referral centre in Israel (1991-2010).

Authors:  A Leiba; O Cohen-Arazi; L Mendel; E J Holtzman; E Grossman
Journal:  J Hum Hypertens       Date:  2015-12-17       Impact factor: 3.012

3.  Hypertension among Outpatients at a General Hospital in South Angola: Prevalence, Awareness, Treatment, and Control.

Authors:  Feliciano C Paquissi; Arminda B P Cuvinje; Almeida B Cuvinje; Arlindo M Paquissi
Journal:  Clin Med Insights Cardiol       Date:  2016-07-03

4.  Profile of patients with hypertensive urgency and emergency presenting to an urban emergency department of a tertiary referral hospital in Tanzania.

Authors:  Patrick J Shao; Hendry R Sawe; Brittany L Murray; Juma A Mfinanga; Victor Mwafongo; Michael S Runyon
Journal:  BMC Cardiovasc Disord       Date:  2018-08-02       Impact factor: 2.298

5.  Prevalence, patterns and factors associated with hypertensive crises in Mulago hospital emergency department; a cross-sectional study.

Authors:  Irene Nakalema; Mark Kaddumukasa; Jane Nakibuuka; Emmy Okello; Martha Sajatovic; Elly Katabira
Journal:  Afr Health Sci       Date:  2019-03       Impact factor: 0.927

6.  Epidemiology of hypertensive crisis in the Buea Regional Hospital, Cameroon.

Authors:  Clovis Nkoke; Jean Jacques Noubiap; Anastase Dzudie; Ahmadou M Jingi; Debimeh Njume; Denis Teuwafeu; Jerry Aseneh; Cyrille Nkouonlack; Alain Menanga; Samuel Kingue
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-09-20       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.